A pilot study of carboplatin (JM8, CBDCA) and chlorambucil in combination for advanced ovarian cancer.

Forty-six patients with previously untreated, advanced ovarian cancer received carboplatin (JM8, CBDCA) and chlorambucil (CLB) to assess the efficacy and toxicity of this combination. Carboplatin 300 mg m-2 was given on day 1 with CLB 10 mg daily for 7, 10 or 14 days; 6 treatment courses were given...

Descripción completa

Detalles Bibliográficos
Autores principales: Harding, M., Kennedy, R., Mill, L., MacLean, A., Duncan, I., Kennedy, J., Soukop, M., Kaye, S. B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1988
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246806/
https://www.ncbi.nlm.nih.gov/pubmed/3064798

Ejemplares similares

Ejemplares similares